LincoBac 300 (Lincomycin) Injection, Swine Antibiotic, 100mL

LincoBac™ 300 Injection is indicated for the treatment of infectious forms of arthritis in swine caused by organisms including staphylococci, streptococci, Erysipelothrix and Mycoplasma spp. It is also indicated for the treatment of mycoplasma pneumonia. The injection contains the proven antibiotic lincomycin. Use in all ages, at all stages of production. Contains 300 mg/mL lincomycin.

• Effective: Contains the proven antibiotic lincomycin in injectable form
• Versatile: Use in all ages, at all stages of production
• Economical: Reduces losses due to profit-robbing arthritic damage
• Safe: Approved by FDA

Dosage and Administration: For arthritis or mycoplasma pneumonia–5mg/lb body weight intramuscularly once daily for three to seven days as needed. One mL LincoBac 300 per 60 lb body weight, will provide 5 mg/lb.

For optimal results, initiate treatment as soon as possible. As with any multi-dose vial, practice aseptic techniques in withdrawing each dose. Adequately clean and disinfect the vial closure prior to entry with a sterile needle and syringe. No vial closure should be entered more than 20 times.

Contraindications

As with all drugs, the use of LincoBac 300 is contraindicated in animals previously found to be hypersensitive to the drug.

Residue Warning: Swine intended for human consumption should not be slaughtered within 48 hours of latest treatment.

Human Warnings

Not for human use. Keep out of reach of children.

Caution: If no improvement is noted within 48 hours, consult a veterinarian.

Adverse Reactions: The intramuscular administration to swine may cause a transient diarrhea or loose stools. Although this effect has rarely been reported, one must be alert to the possibility that it may occur. Should this occur, it is important that the necessary steps be taken to prevent the effects of dehydration.